FEZF2 and nasopharyngeal carcinoma: Over the past several years, radiotherapy equipment and techniques have been improved tremendously, and several genes, such as BCAT1 (21), MST1R (22) and FEZF2 (23), were indicated to be aberrantly expressed in NPC.